In a significant stride for the fields of regenerative medicine and implantable medical devices, Hyderabad-based biotechnology firm BioVaram has joined forces with Japan's Teijin Limited. Announced on Thursday, this collaboration seeks to expand the footprint of these advanced medical solutions across India and Japan.

The partnership involves pursuing regulatory approvals and commercialization of Teijin's SYNFOLIUMⓇ, a cardiovascular repair patch, within India. Simultaneously, it aims to introduce BioVaram's cutting-edge product lineup to the Japanese market. This bilateral engagement underscores both companies' commitments to innovation and expansion.

This agreement also facilitates the development and commercialization of BioVaram's technologies in Japan, which includes pioneering exos

See Full Page